These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 22378688

  • 1. Value of routine bone marrow examination in pediatric acute myeloid leukemia (AML): a study of the Dutch Childhood Oncology Group (DCOG).
    Hageman IM, Peek AM, de Haas V, Damen-Korbijn CM, Kaspers GJ.
    Pediatr Blood Cancer; 2012 Dec 15; 59(7):1239-44. PubMed ID: 22378688
    [Abstract] [Full Text] [Related]

  • 2. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Eur J Haematol; 2004 Feb 15; 72(2):89-106. PubMed ID: 14962246
    [Abstract] [Full Text] [Related]

  • 3. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P.
    Haematologica; 2000 Nov 15; 85(11 Suppl):47-53. PubMed ID: 11268324
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals.
    Ommen HB, Nyvold CG, Braendstrup K, Andersen BL, Ommen IB, Hasle H, Hokland P, Ostergaard M.
    Br J Haematol; 2008 Jun 15; 141(6):782-91. PubMed ID: 18410450
    [Abstract] [Full Text] [Related]

  • 6. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
    Doubek M, Palasek I, Pospisil Z, Borsky M, Klabusay M, Brychtova Y, Jurcek T, Jeziskova I, Krejci M, Dvorakova D, Mayer J.
    Exp Hematol; 2009 Jun 15; 37(6):659-72. PubMed ID: 19463768
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia.
    Lee JH, Choi SJ, Lee JH, Seol M, Lee YS, Ryu SG, Park CJ, Chi HS, Lee MS, Yun S, Lee JS, Lee KH.
    Haematologica; 2005 Oct 15; 90(10):1380-8. PubMed ID: 16219575
    [Abstract] [Full Text] [Related]

  • 9. Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remission.
    Gorin NC, Labopin M, Blaise D, Reiffers J, Meloni G, Michallet M, de Witte T, Attal M, Rio B, Witz F, Fouillard L, Willemze R, Rocha V, Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation.
    J Clin Oncol; 2009 Aug 20; 27(24):3987-93. PubMed ID: 19597030
    [Abstract] [Full Text] [Related]

  • 10. Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.
    MRD-AML-BFM Study GroupDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany. langebrake.claudia@mh-hannover.de, Langebrake C, Creutzig U, Dworzak M, Hrusak O, Mejstrikova E, Griesinger F, Zimmermann M, Reinhardt D.
    J Clin Oncol; 2006 Aug 01; 24(22):3686-92. PubMed ID: 16877738
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul 01; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
    Starý J, Kobylka P, Sedlácek P, Komrska V, Vávra V, Syrůcková Z, Smísek P, Hrubá A, Korínková P, Matĕjková E, Cukrová V, Dolezalová L, Loudová M, Sejkorová J, Kvĕch J.
    Cas Lek Cesk; 1998 Jun 15; 137(12):363-7. PubMed ID: 9721472
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
    Ravindranath Y, Yeager AM, Chang MN, Steuber CP, Krischer J, Graham-Pole J, Carroll A, Inoue S, Camitta B, Weinstein HJ.
    N Engl J Med; 1996 May 30; 334(22):1428-34. PubMed ID: 8618581
    [Abstract] [Full Text] [Related]

  • 17. Routine bone marrow punctures during remission of acute myelogenous leukemia.
    Müller E, Sauter C.
    Leukemia; 1992 May 30; 6(5):419. PubMed ID: 1593905
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC, Huxol H, Müller R, Speck B, Nissen C.
    Exp Hematol; 1993 Nov 30; 21(12):1517-21. PubMed ID: 8405233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.